1st autologous IPS cell clinical trial for vision loss in the US
1st autologous IPS cell clinical trial for vision loss in the US
The NIH announced the launch of the 1st autologous induced pluripotent stem (IPS) cell trial for vision loss in the U.S., focused on macular degeneration.
Kapil Bharti, Ph.D., leader of new IPS cell clinical trial for macular degeneration at the NEI. Photo is screenshot from NEI YouTube video.
The protocol is based on a solid foundation of pre-clinical animal studies:
“Researchers at the National…
View On WordPress









